表紙
市場調査レポート

韓国における創傷管理処置市場の見通し

South Korea Wound Care Management Procedures Outlook to 2020

発行 GlobalData 商品コード 315223
出版日 ページ情報 英文 40 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
韓国における創傷管理処置市場の見通し South Korea Wound Care Management Procedures Outlook to 2020
出版日: 2014年10月01日 ページ情報: 英文 40 Pages
概要

当レポートでは、韓国における創傷管理処置市場について、創傷管理処置全体およびオストミー処置、組織工学による皮膚置換処置、創傷デブリードマン処置のカテゴリー別に調査しており、その売上、販売数の実績と今後の予測などをまとめています。

第1章 目次

第2章 イントロダクション

  • 本レポートについて
  • 創傷管理処置の分類
  • 本レポートで取り上げている処置の定義

第3章 創傷管理の韓国市場

  • 創傷管理の韓国市場:実績と予測
  • 創傷管理の韓国市場 - 処置数ベースのカテゴリー比較:実績と予測
  • 創傷管理の韓国市場:実績
  • 創傷管理の韓国市場:予測

第4章 オストミー処置の韓国市場

  • オストミー処置の韓国市場:実績
  • オストミー処置の韓国市場:予測

第5章 組織工学による皮膚置換処置の韓国市場

  • 組織工学による皮膚置換処置の韓国市場:実績
  • 組織工学による皮膚置換処置の韓国市場:予測
    • 生物学的皮膚置換処置の韓国市場:実績
      • 同種移植処置の韓国市場:実績
    • 生物学的皮膚置換処置の韓国市場:予測
      • 同種移植処置の韓国市場:予測

第6章 創傷デブリードマン処置の韓国市場

  • 創傷デブリードマン処置の韓国市場:実績
  • 創傷デブリードマン処置の韓国市場:予測

第7章 付録

目次
Product Code: GDMEMC0053PDB

GlobalData's new report, "South Korea Wound Care Management Procedures Outlook to 2020", provides key procedures data on the South Korea Wound Care Management Procedures. The report provides procedure volumes within market categories - Tissue Engineered - Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

  • Procedure volumes data for Wound Care Management Procedures segments - Tissue Engineered - Skin Substitute Procedures (Synthetic Skin Substitute Procedures, Biosynthetic Skin Substitute Procedures and Biologic Skin Substitute Procedures ((Allograft Cellular and Acellular Procedures) and Xenograft Acellular Procedures), Wound Debridement Procedures and Ostomy Procedures.
  • Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

  • Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Develop market-entry and market expansion strategies.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About
  • 2.2. Wound Care Management Procedures Segmentation
  • 2.3. Definitions of Procedures Covered in the Report

3. Wound Care Management, South Korea

  • 3.1. Wound Care Management, South Korea, 2005-2020
  • 3.2. Wound Care Management, South Korea Category Comparison by Procedures, 2005-2020
  • 3.3. Wound Care Management, South Korea, 2005-2013
  • 3.4. Wound Care Management, South Korea, 2013-2020

4. Ostomy Procedures, South Korea

  • 4.1. Ostomy Procedures, South Korea, 2005-2013
  • 4.2. Ostomy Procedures, South Korea, 2013-2020

5. Tissue Engineered - Skin Substitute Procedures, South Korea

  • 5.1. Tissue Engineered - Skin Substitute Procedures, South Korea, 2005-2013
  • 5.2. Tissue Engineered - Skin Substitute Procedures, South Korea, 2013-2020
    • 5.2.1. Biologic Skin Substitute Procedures, South Korea, 2005-2013
      • 5.2.1.1. Allograft Procedures, South Korea, 2005-2013
    • 5.2.2. Biologic Skin Substitute Procedures, South Korea, 2013-2020
      • 5.2.2.1. Allograft Procedures, South Korea, 2013-2020

6. Wound Debridement Procedures, South Korea

  • 6.1. Wound Debridement Procedures, South Korea, 2005-2013
  • 6.2. Wound Debridement Procedures, South Korea, 2013-2020

7. Appendix

  • 7.1. Research Methodology
    • 7.1.1. Coverage
    • 7.1.2. Secondary Research
    • 7.1.3. Primary Research
    • 7.1.4. Market Modeling and Forecasting
    • 7.1.5. Company Share Analysis
    • 7.1.6. Distribution Share Analysis
  • 7.2. Expert Panel
  • 7.3. GlobalData Consulting
  • 7.4. Contact Us
  • 7.5. Disclaimer

List of Tables

  • Table 1: Wound Care Management, South Korea, 2005-2020
  • Table 2: Wound Care Management, South Korea Category Comparison by Procedures, 2005-2020
  • Table 3: Wound Care Management, South Korea, Historic, 2005-2013
  • Table 4: Wound Care Management, South Korea, Forecast, 2013-2020
  • Table 5: Ostomy Procedures, South Korea, Historic, 2005-2013
  • Table 6: Ostomy Procedures, South Korea, Forecast, 2013-2020
  • Table 7: Tissue Engineered - Skin Substitute Procedures, South Korea, Historic, 2005-2013
  • Table 8: Tissue Engineered - Skin Substitute Procedures, South Korea, Forecast, 2013-2020
  • Table 9: Biologic Skin Substitute Procedures, South Korea, Historic, 2005-2013
  • Table 10: Allograft Procedures, South Korea, Historic, 2005-2013
  • Table 11: Biologic Skin Substitute Procedures, South Korea, Forecast, 2013-2020
  • Table 12: Allograft Procedures, South Korea, Forecast, 2013-2020
  • Table 13: Wound Debridement Procedures, South Korea, Historic, 2005-2013
  • Table 14: Wound Debridement Procedures, South Korea, Forecast, 2013-2020
  • Table 15: Total Number of Primary Research Participants, Wound Care Management, by Country

List of Figures

  • Figure 1: Wound Care Management, South Korea, 2005-2020
  • Figure 2: Wound Care Management, South Korea Category Comparison by Procedures, 2005-2020
  • Figure 3: Wound Care Management, South Korea, Historic, 2005-2013
  • Figure 4: Wound Care Management, South Korea, Forecast, 2013-2020
  • Figure 5: Ostomy Procedures, South Korea, Historic, 2005-2013
  • Figure 6: Ostomy Procedures, South Korea, Forecast, 2013-2020
  • Figure 7: Tissue Engineered - Skin Substitute Procedures, South Korea, Historic, 2005-2013
  • Figure 8: Tissue Engineered - Skin Substitute Procedures, South Korea, Forecast, 2013-2020
  • Figure 9: Biologic Skin Substitute Procedures, South Korea, Historic, 2005-2013
  • Figure 10: Allograft Procedures, South Korea, Historic, 2005-2013
  • Figure 11: Biologic Skin Substitute Procedures, South Korea, Forecast, 2013-2020
  • Figure 12: Allograft Procedures, South Korea, Forecast, 2013-2020
  • Figure 13: Wound Debridement Procedures, South Korea, Historic, 2005-2013
  • Figure 14: Wound Debridement Procedures, South Korea, Forecast, 2013-2020
  • Figure 15: GlobalData Epidemiology-Based Forecasting Model
  • Figure 16: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 17: Primary Interviews by Participant Type (%)
Back to Top